Hyper Corporation Inc.

KOSDAQ:A065650 Voorraadrapport

Marktkapitalisatie: ₩128.7b

Hyper Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Hyun-Sang Muk

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Should Medifron DBT (KOSDAQ:065650) Be Disappointed With Their 48% Profit?

Mar 15
Should Medifron DBT (KOSDAQ:065650) Be Disappointed With Their 48% Profit?

Despite Lacking Profits Medifron DBT (KOSDAQ:065650) Seems To Be On Top Of Its Debt

Nov 29
Despite Lacking Profits Medifron DBT (KOSDAQ:065650) Seems To Be On Top Of Its Debt

CEO

Hyun-Sang Muk (65 yo)

no data

Tenure

Mr. Muk serves as Outside Director at Insung Information Co., Ltd., Chief Executive Officer and Representative Director at Hyper Corporation Inc. (formerly known as Medifron DBT Co., Ltd.).